{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:29:22Z","timestamp":1769718562068,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-018-0170-4","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T08:31:09Z","timestamp":1526459469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structure-based optimization of tyrosine kinase inhibitors: a molecular docking study"],"prefix":"10.1007","volume":"7","author":[{"given":"David Ebuka","family":"Arthur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamu","family":"Uzairu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Eyije","family":"Abechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon Adamu","family":"Shallangwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"issue":"3","key":"170_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","volume":"235","author":"R Abagyan","year":"1994","unstructured":"Abagyan R, Totrov M (1994) Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 235(3):983\u20131002","journal-title":"J Mol Biol"},{"issue":"6","key":"170_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1074\/mcp.M400159-MCP200","volume":"4","author":"J An","year":"2005","unstructured":"An J, Totrov M, Abagyan R (2005) Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol Cell Proteom 4(6):752\u2013761","journal-title":"Mol Cell Proteom"},{"issue":"2","key":"170_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ijc.2910530206","volume":"53","author":"O Engebraaten","year":"1993","unstructured":"Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD (1993) Effects of EGF, BFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J cancer 53(2):209\u2013214","journal-title":"Int J cancer"},{"issue":"42","key":"170_CR4","doi-asserted-by":"publisher","first-page":"11140","DOI":"10.1002\/anie.201405820","volume":"53","author":"DA Evans","year":"2014","unstructured":"Evans DA (2014) History of the Harvard ChemDraw project. Angew Chem Int Ed 53(42):11140\u201311145","journal-title":"Angew Chem Int Ed"},{"issue":"2","key":"170_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0163-7258(02)00179-1","volume":"93","author":"D Fabbro","year":"2002","unstructured":"Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Chaudhuri B (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 93(2):79\u201398","journal-title":"Pharmacol Ther"},{"issue":"2","key":"170_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1110\/ps.19202","volume":"11","author":"J Fern\u00e1ndez-Recio","year":"2002","unstructured":"Fern\u00e1ndez-Recio J, Totrov M, Abagyan R (2002) Soft protein\u2013protein docking in internal coordinates. Protein Sci 11(2):280\u2013291","journal-title":"Protein Sci"},{"issue":"1","key":"170_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/prot.10383","volume":"52","author":"J Fern\u00e1ndez-Recio","year":"2003","unstructured":"Fern\u00e1ndez-Recio J, Totrov M, Abagyan R (2003) ICM-DISCO docking by global energy optimization with fully flexible side-chains. Proteins Struct Funct Bioinf 52(1):113\u2013117","journal-title":"Proteins Struct Funct Bioinf"},{"key":"170_CR8","doi-asserted-by":"crossref","unstructured":"Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA (2002). Epidermal growth factor receptor family in lung cancer and premalignancy. In: Paper presented at the seminars in oncology","DOI":"10.1053\/sonc.2002.31520"},{"issue":"1","key":"170_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1091\/mbc.4.1.121","volume":"4","author":"CK Goldman","year":"1993","unstructured":"Goldman CK, Kim J, Wong W, King V, Brock T, Gillespie G (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4(1):121\u2013133","journal-title":"Mol Biol Cell"},{"key":"170_CR10","volume-title":"Chemistry with computation: an introduction to SPARTAN","author":"WJ Hehre","year":"1995","unstructured":"Hehre WJ, Huang WW (1995) Chemistry with computation: an introduction to SPARTAN: Wavefunction, Inc, Irvine"},{"issue":"5","key":"170_CR11","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/13043","volume":"1","author":"S Huang","year":"1999","unstructured":"Huang S, Ingber DE (1999) The structural and mechanical complexity of cell-growth control. Nature Cell Biol 1(5):E131\u2013E138","journal-title":"Nature Cell Biol"},{"issue":"5","key":"170_CR12","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1021\/ci049794h","volume":"44","author":"Z Li","year":"2004","unstructured":"Li Z, Wan H, Shi Y, Ouyang P (2004) Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch. J Chem Inf Comput Sci 44(5):1886\u20131890","journal-title":"J Chem Inf Comput Sci"},{"key":"170_CR13","unstructured":"MolSoft I (2000) 2.8 program manual. MolSoft LLC, San Diego"},{"issue":"2","key":"170_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cancers3021513","volume":"3","author":"M Oliveira-Cunha","year":"2011","unstructured":"Oliveira-Cunha M, Newman WG, Siriwardena AK (2011) Epidermal growth factor receptor in pancreatic cancer. Cancers 3(2):1513\u20131526","journal-title":"Cancers"},{"issue":"suppl 1","key":"170_CR15","doi-asserted-by":"publisher","first-page":"11842","DOI":"10.1073\/pnas.2034201100","volume":"100","author":"E Passegu\u00e9","year":"2003","unstructured":"Passegu\u00e9 E, Jamieson CH, Ailles LE, Weissman IL (2003) Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci 100(suppl 1):11842\u201311849.s","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"170_CR16","first-page":"1523","volume":"151","author":"A Petit","year":"1997","unstructured":"Petit A, Rak J, Hung M-C, Rockwell P, Goldstein N, Fendly B, Kerbel RS (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 151(6):1523","journal-title":"Am J Pathol"},{"issue":"6859","key":"170_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105\u2013111","journal-title":"Nature"},{"issue":"2","key":"170_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bmcl.2004.10.085","volume":"15","author":"ME Salvati","year":"2005","unstructured":"Salvati ME, Balog A, Shan W, Wei DD, Pickering D, Attar RM, Weinmann R (2005) Structure based approach to the design of bicyclic-1H-isoindole-1, 3 (2H)-dione based androgen receptor antagonists. Bioorg Med Chem Lett 15(2):271\u2013276","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"170_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000217979","volume":"17","author":"T Shibata","year":"1996","unstructured":"Shibata T, Kawano T, Nagayasu H, Okumura K, Arisue M, Hamada J-I, Hosokawa M (1996) Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumor Biol 17(3):168\u2013175","journal-title":"Tumor Biol"},{"issue":"10","key":"170_CR20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1182\/blood-2009-01-197186","volume":"114","author":"S Soverini","year":"2009","unstructured":"Soverini S, Gnani A, Colarossi S, Castagnetti F, Abruzzese E, Paolini S, Gozzini A (2009) Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second-or third-line tyrosine kinase inhibitors. Blood 114(10):2168\u20132171","journal-title":"Blood"},{"issue":"48","key":"170_CR21","doi-asserted-by":"publisher","first-page":"46265","DOI":"10.1074\/jbc.M207135200","volume":"277","author":"J Stamos","year":"2002","unstructured":"Stamos J, Sliwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277(48):46265\u201346272","journal-title":"J Biol Chem"},{"issue":"3","key":"170_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"VN Viswanadhan","year":"1989","unstructured":"Viswanadhan VN, Ghose AK, Revankar GR, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 29(3):163\u2013172","journal-title":"J Chem Inf Comput Sci"},{"issue":"5","key":"170_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc2126","volume":"7","author":"E Weisberg","year":"2007","unstructured":"Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD (2007) Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 7(5):345\u2013356","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"170_CR24","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","volume":"64","author":"SM Wilhelm","year":"2004","unstructured":"Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, McHugh M (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64(19):7099\u20137109","journal-title":"Cancer Res"},{"issue":"1","key":"170_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1471-4914(01)02217-1","volume":"8","author":"E Zwick","year":"2002","unstructured":"Zwick E, Bange J, Ullrich A (2002) Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol Med 8(1):17\u201323","journal-title":"Trends Mol Med"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-018-0170-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:29:15Z","timestamp":1557970155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-018-0170-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1007\/s13721-018-0170-4","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"7 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}